Irisin levels before and after physical activity among school-age children with different BMI: A direct relation with leptin

Obesity

Volumn 23, Issue 4, 2015, Pages 729-732

  Palacios González, Berenice ^a   Vadillo Ortega, Felipe ^a   Polo Oteyza, Ernestina ^b   Sánchez, Teresa ^c   Ancira Moreno, Monica ^a   Romero Hidalgo, Sandra ^d   Meráz, Noemi ^a   Antuna Puente, Barbara ^d  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b Fundacion Mexicana para la Salud AC   (Mexico)

^c Secretaria de Educacion Publica   (Mexico)

^d INSTITUTO NACIONAL DE MEDICINA GENÓMICA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; IRISIN; LEPTIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; FIBRONECTIN; FNDC5 PROTEIN, HUMAN;

ADIPOSE TISSUE; ARTICLE; BODY MASS; BODY WEIGHT; CHILD; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; RUNNING; SCHOOL CHILD; SEX DIFFERENCE; WALKING; BLOOD; COMPARATIVE STUDY; EXERCISE; FOLLOW UP; METABOLISM; PEDIATRIC OBESITY; PHYSIOLOGY;

BIOLOGICAL MARKERS; BODY MASS INDEX; BODY WEIGHT; CHILD; EXERCISE; FEMALE; FIBRONECTINS; FOLLOW-UP STUDIES; HUMANS; LEPTIN; MALE; PEDIATRIC OBESITY;

EID: 84925749343     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.21029     Document Type: Article

References (19)

1. de Onis M, Blossner M, Borghi E., Global prevalence and trends of overweight and obesity among preschool children. Am J Clin Nutr 2010; 92: 1257-1264.
2. Gutierrez JP R-Dj, Shamah-Levy T, Villalpando-Hernández S, Franco A, Cuevas-Nasu L, Romero-Martínez M, Hernández-Ávila M., Encuesta Nacional de Salud y Nutriciõn 2012. Instituto Nacional de Salud Pública: Mexico, 2012.
3. Franks PW, Hanson RL, Knowler WC, Sievers ML, Bennett PH, Looker HC., Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med 2010; 362: 485-493.
4. Perichart-Perera O, Balas-Nakash M, Schiffman-Selechnik E, Barbato-Dosal A, Vadillo-Ortega F., Obesity increases metabolic syndrome risk factors in school-aged children from an urban school in Mexico city. J Am Diet Assoc 2007; 107: 81-91.
5. Bostrom P, Wu J, Jedrychowski MP, et al. A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012; 481: 463-468.
6. Huh JY, Panagiotou G, Mougios V, et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metab Clin Exp 2012; 61: 1725-1738.
7. Lecker SH, Zavin A, Cao P, et al. Expression of the irisin precursor FNDC5 in skeletal muscle correlates with aerobic exercise performance in patients with heart failure. Circ Heart Fail 2012; 5: 812-818.
8. Timmons JA, Baar K, Davidsen PK, Atherton PJ., Is irisin a human exercise gene? Nature 2012; 488: E9-10; discussion E10-11.
9. Aydin S, Aydin S, Kuloglu T, et al. Alterations of irisin concentrations in saliva and serum of obese and normal-weight subjects, before and after 45 min of a Turkish bath or running. Peptides 2013; 50: 13-18.
10. Kraemer RR, Shockett P, Webb ND, Shah U, Castracane VD., A transient elevated irisin blood concentration in response to prolonged, moderate aerobic exercise in young men and women. Horm Metab Res 2014; 46: 150-154.
11. Huh JY, Mougios V, Kabasakalis A, et al. Exercise-induced irisin secretion is independent of age or fitness level and increased irisin may directly modulate muscle metabolism through AMPK activation. J Clin Endocrinol Metab 2014; 11: E2154-E2161.
12. Crujeiras AB, Cueva J, Vieito M, et al. Association of breast cancer and obesity in a homogeneous population from Spain. J Endocrinol Investig 2012; 35: 681-685.
13. Stengel A, Hofmann T, Goebel-Stengel M, Elbelt U, Kobelt P, Klapp BF., Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity-correlation with body mass index. Peptides 2013; 39: 125-130.
14. Pardo M, Crujeiras AB, Amil M, et al. Association of irisin with fat mass, resting energy expenditure, and daily activity in conditions of extreme body mass index. Int J Endocrinol 2014; 2014: 857270.
15. Moreno-Navarrete JM, Ortega F, Serrano M, et al. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J Clin Endocrinol Metab 2013; 98: E769-778.
16. Lopez-Legarrea P, de la Iglesia R, Crujeiras AB, et al. Higher baseline irisin concentrations are associated with greater reductions in glycemia and insulinemia after weight loss in obese subjects. Nutr Diabetes 2014; 4: e110.
17. Daskalopoulou SS, Cooke AB, Gomez YH, et al. Plasma irisin levels progressively increase in response to increasing exercise workloads in young, healthy, active subjects. Eur J Endocrinol 2014; 171: 343-352.
18. Norheim F, Langleite TM, Hjorth M, et al. The effects of acute and chronic exercise on PGC-1alpha, irisin and browning of subcutaneous adipose tissue in humans. FEBS J 2014; 281: 739-749.
19. Bluher S, Panagiotou G, Petroff D, et al. Effects of a 1-year exercise and lifestyle intervention on irisin, adipokines, and inflammatory markers in obese children. Obesity 2014; 7: 1701-1708.